Live Evaluations
Non-Steroidal Topical Therapies in Psoriasis and Atopic Dermatitis: The Paradigm Shift
About
Non-Steroidal Topical Therapies in Psoriasis and Atopic Dermatitis: The Paradigm Shift
This activity supported by an educational grant from Dermavant Sciences, Inc.
Learning Objectives
At the completion of this activity, participants should be better able to:
Identify non-steroidal topical agents for the treatment of atopic dermatitis and psoriasis
Discuss strategies to individualize care with topical non-steroidal therapies for the management of atopic dermatitis and psoriasis
Intended Audience
Faculty
George Lewitt, MD
Dermatologist
Illinois Dermatology Institute
Chicago, IL
Linda Stein Gold, MD
Director Clinical Research
Henry Ford Health System
Detroit, MI
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Nevada and CMEsquared. The University of Nevada is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The University of Nevada designates this enduring activity for a maximum of 0.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures & Disclaimers
CONFLICTS OF INTEREST/DISCLOSURES
In accordance with the ACCME Standards for Commercial Support, balance, independence, objectivity, and scientific rigor are ensured in all CME activities. This requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with any ineligible companies. In addition, the content of this material has been approved by an independent peer reviewer.
Disclosures are as follows:
Grant/Research Support: Arcutis, BMS, Incyte, Dermavant, Galderma, Lilly, AbbVie
Consultant: Arcutis, BMS, Incyte, Dermavant, Galderma, Lilly, AbbVie
Speakers’ Bureau or Honoraria: Leo, AbbVie, Almirall, Galderma, Pfizer, Sanofi, Regeneron
The planners have disclosed that they have no relevant financial relationships with any Ineligible Company in the past 24 months.
The University of Nevada discloses that all relevant conflicts have been satisfactorily mitigated.